STAAR Surgical Co. (STAA)
23.47
-0.10
(-0.45%)
USD |
NASDAQ |
Sep 04, 16:00
23.49
+0.02
(+0.09%)
After-Hours: 20:00
STAAR Surgical Research and Development Expense (Quarterly) : 9.769M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.769M |
| March 31, 2026 | 9.716M |
| December 31, 2025 | 9.042M |
| September 30, 2025 | 9.009M |
| June 30, 2025 | 10.08M |
| March 31, 2025 | 13.48M |
| December 31, 2024 | 12.04M |
| September 30, 2024 | 14.50M |
| June 30, 2024 | 14.05M |
| March 31, 2024 | 13.38M |
| December 31, 2023 | 10.87M |
| September 30, 2023 | 11.47M |
| June 30, 2023 | 11.76M |
| March 31, 2023 | 10.31M |
| December 31, 2022 | 9.79M |
| September 30, 2022 | 9.616M |
| June 30, 2022 | 8.636M |
| March 31, 2022 | 7.941M |
| December 31, 2021 | 9.072M |
| September 30, 2021 | 8.271M |
| June 30, 2021 | 8.26M |
| March 31, 2021 | 8.259M |
| December 31, 2020 | 8.958M |
| September 30, 2020 | 8.751M |
| June 30, 2020 | 7.311M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.898M |
| December 31, 2019 | 7.409M |
| September 30, 2019 | 6.156M |
| June 30, 2019 | 6.098M |
| March 31, 2019 | 5.635M |
| December 31, 2018 | 5.705M |
| September 30, 2018 | 5.57M |
| June 30, 2018 | 5.346M |
| March 31, 2018 | 5.043M |
| December 31, 2017 | 5.626M |
| September 30, 2017 | 4.429M |
| June 30, 2017 | 4.767M |
| March 31, 2017 | 4.783M |
| December 31, 2016 | 4.275M |
| September 30, 2016 | 4.453M |
| June 30, 2016 | 4.659M |
| March 31, 2016 | 6.906M |
| December 31, 2015 | 3.961M |
| September 30, 2015 | 3.684M |
| June 30, 2015 | 3.536M |
| March 31, 2015 | 3.579M |
| December 31, 2014 | 3.245M |
| September 30, 2014 | 3.137M |
| June 30, 2014 | 2.498M |
| March 31, 2014 | 3.484M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 370.40M |
| Enovis Corp. | 31.69M |
| Stryker Corp. | 424.00M |
| Zimmer Biomet Holdings, Inc. | 104.80M |
| Edwards Lifesciences Corp. | 278.90M |